Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.8K Hold
74
0.01% 160
2026
Q1
$26K Hold
74
0.01% 153
2025
Q4
$24.2K Hold
74
0.01% 148
2025
Q3
$20.9K Hold
74
0.01% 148
2025
Q2
$20.7K Sell
74
-297
-80% -$84.1K 0.01% 146
2025
Q1
$116K Sell
371
-623
-63% -$184K 0.05% 114
2024
Q4
$259K Hold
994
0.11% 94
2024
Q3
$320K Hold
994
0.13% 94
2024
Q2
$311K Sell
994
-133
-12% -$39.1K 0.13% 96
2024
Q1
$320K Sell
1,127
-10
-0.9% -$2.93K 0.13% 94
2023
Q4
$327K Buy
1,137
+5
+0.4% +$1.36K 0.14% 79
2023
Q3
$304K Buy
+1,132
New +$282K 0.15% 69

Other funds holding AMGN

Rogco LP's AMGN Position: Q2 2026 in Review

Rogco LP held its Amgen (AMGN) position steady in Q2 2026 at 74 shares worth $26.8K. The position accounts for 0.01% of the portfolio, ranked #160.

Rogco LP first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $327K in Q4 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rogco LP held 74 shares of Amgen worth $26.8K as of Q2 2026.
  • Rogco LP left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.01% of Rogco LP's portfolio in Q2 2026, its #160 holding.
  • Rogco LP first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • Rogco LP's Amgen position peaked at $327K in Q4 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rogco LP's 13F filing for Q2 2026, filed 30 Jul 2026.